A daisy-family rhizome long used in Chinese herbal practice for digestion, fluid balance, and energy. Best human evidence supports relief of irritable-bowel-type symptoms and fewer chemotherapy-related digestive and immune side effects; longevity claims rest on tradition alone. Generally well tolerated. Almost all trials test multi-herb formulas, not the herb alone, so the case stays uncertain. (Full Review)

Protocol

Standard Dose

6–12 g/day

Dried rhizome decocted, usually within a multi-herb formula

Dosing Pattern

Split, 2–3×/day

Decoctions divided across the day to suit short constituent exposure

Timing

Warm, around meals

Traditionally taken warm, between or before meals; no robust optimal time

Time to effect

Digestive Symptoms

Days to a few weeks

Develops with consistent dosing rather than immediately

Tonic & Immune Effects

Gradual

Where present, expected to develop slowly over time

Benefits

Medium: Relief of functional gastrointestinal symptoms; reduction of chemotherapy-related digestive and immune toxicity

Low: Prevention of chemotherapy-induced nerve damage; immune function support; hepatoprotection

Speculative: Longevity and healthy-aging effects; bone health and anti-osteoporotic activity

Contraindications

Pregnancy and breastfeeding

Transplant recipients and others on essential immunosuppression

Known Asteraceae-family plant allergy

Scheduled surgery (discontinue 1–2 weeks beforehand)

Key Interactions

Anticoagulant and antiplatelet drugs (warfarin, clopidogrel, aspirin)

Antidiabetic medications (metformin, sulfonylureas, insulin)

Sedatives and CNS depressants (benzodiazepines, barbiturates)

Immunosuppressants (corticosteroids, ciclosporin, tacrolimus)

Risk & Side Effects

Medium: Product quality and contamination risk; mild gastrointestinal upset

Low: Allergic or hypersensitivity reactions

Speculative: Unwanted immune stimulation in autoimmune disease; hepatic effects at atypical exposures

Monitoring

Marker	Target	Why
ALT / AST	~10–26 U/L each	Screens liver function before and during sustained use
Fasting blood glucose	70–90 mg/dL	Detects additive glucose-lowering if combined with antidiabetic agents
INR (warfarin users only)	Within individual therapeutic target	Detects shifts in clotting from theoretical bleeding interaction
eGFR	>90 mL/min/1.73 m²	Confirms adequate clearance capacity before sustained use
hs-CRP	<1.0 mg/L	Tracks systemic inflammation the herb may influence

Cadence: Reassess symptoms and tolerability at 2–4 weeks, then every 3–6 months; more frequent glucose or clotting checks if on interacting medications

Qualitative Assessment

Digestive comfort — reduced bloating, more regular bowel habits, improved appetite
Energy levels and sense of vitality across the day
Frequency of minor infections or perceived immune resilience
General tolerability — absence of dry mouth, nausea, or drowsiness

Atractylodis Macrocephalae for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment